中国医院药剂师对药监知识,态度和实践的认识
Yinchu Cheng1,2,3, Tingting Qiu1,3, Xiaole Zhang4
1Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Therapeutic advances in drug safety
|October 10, 2025
概括
中国的医院药剂师表现出适度的知识和态度,但在药物监测方面有强有力的实践. 需要有针对性的培训,以提高对药监管范围和责任的理解,以提高患者安全.
科学领域:
- 药监和药物安全 药监和药物安全
- 制药实践研究 研究 药学实践研究
- 医疗保健 专业教育 医疗保健 专业教育
背景情况:
- 药物监测对于患者安全至关重要,医院药剂师发挥着至关重要的作用.
- 中国医院药剂师在药物监测方面的知识,态度和实践 (KAP) 缺乏研究.
- 这项研究解决了中国医院药剂师在了解药监 KAP 方面的差距.
研究的目的:
- 评估医院药剂师在中国各地关于药监督的知识,态度和实践 (KAP).
- 确定影响医院药剂师KAP水平的因素.
- 为改善中国医院的药物监督系统提供有针对性的干预信息.
主要方法:
- 一项全国性的横截面研究,涉及来自2145家医院的9724名医院药剂师.
- 使用结构化问卷和多阶段抽样方法收集的数据.
- 描述性统计和多变量后勤回归分析了KAP和影响因素.
主要成果:
- 高绩效分数 (≥4/5) 观察到22.2%的知识,44.2%的态度和68.0%的实践.
- 存在重大误解,包括错误地将责任赋予机构 (50.1%),并将药物监督定义为仅仅是ADR报告 (36.2%).
- 虽然向监管机构报告的数量很高,但27.8%的人不经常向制药公司报告严重的副作用;95.5%的人希望接受药物监管培训.
结论:
- 在中国,医院药剂师对药监督的知识和态度需要得到实质性的改进.
- 提高对药监管范围和责任的理解至关重要.
- 加强医疗机构与营销许可持有者 (MAHs) 之间的合作是必不可少的,特别是针对目标药剂师群体.
相关概念视频
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
252
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
252
01:22Healthcare Associated Infections II: Preventive Measures
3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
227
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
227
01:12Analysis of Population Pharmacokinetic Data
677
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
677
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
150
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
150